Bristol-Myers Squibb Company Reaffirms 2008 Earnings Guidance

NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE:BMY) today reaffirmed its 2008 earnings guidance for fully diluted earnings per share from continuing operations on a GAAP basis to be between $1.36 and $1.46. The company also reaffirms its 2008 fully diluted earnings per share from continuing operations guidance on a non-GAAP basis to be between $1.60 and $1.70. This guidance assumes that the financial results of the ConvaTec business, which will be sold, will be treated as discontinued operations for all of 2008.

MORE ON THIS TOPIC